NeuroVentures is a venture capital firm.
Business Model:
Revenue: $7.2M
Employees: 2-10
Address: 0 Court Sq
City: Charlottesville
State: VA
Zip: 22902
Country: US
NeuroVentures is a venture capital firm dedicated to investing in companies focused on the discovery, development and marketing of new drugs, medical devices and other therapeutics and technologies to treat central nervous system disorders.
Contact Phone:
+14342971000
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
9/2010 | NeurAxon | Debt Financing | 0 |
8/2006 | Acumen Pharmaceuticals | Venture Round | 0 |
7/2003 | Cyberkinetics | Series A | 9.3M |
2/2004 | Kadmus Pharmaceuticals | Series A | 0 |
7/2002 | Scion Pharmaceuticals | Series B | 0 |
7/2004 | NeurAxon | Series A | 1.9M |
8/2007 | NeurAxon | Series B | 32M |
2/2001 | Proxima Therapeutics | Series D | 17M |
11/2003 | Saegis Pharmaceuticals | Series B | 30M |
3/2008 | BrainCells | Series B | 30M |
7/2005 | BrainCells | Series A | 0 |
9/2010 | NeurAxon | Debt Financing | 0 |
3/2008 | BrainCells | Series B | 0 |
8/2007 | NeurAxon | Series B | 0 |
8/2006 | Acumen Pharmaceuticals | Venture Round | 0 |
7/2005 | BrainCells | Series A | 0 |
7/2004 | NeurAxon | Series A | 0 |
2/2004 | Kadmus Pharmaceuticals | Series A | 0 |
11/2003 | Saegis Pharmaceuticals | Series B | 0 |
7/2003 | Cyberkinetics | Series A | 0 |
7/2002 | Scion Pharmaceuticals | Series B | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|